BridgeBio Pharma, Inc. (BBIO) Ownership

$73.64

$1.12 (-1.5%)
Last update: 04:00 PM EST
Day's range
$72.38
Day's range
$74.86

BridgeBio Pharma, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 11/07/2025 16.83 M $874.26 M   2.11% 8.83%
VIKING GLOBAL INVESTORS LP 11/14/2025 15.98 M $829.89 M   -13.89% 8.39%
BLACKROCK, INC. 11/12/2025 14.41 M $748.52 M   1.06% 7.56%
KOHLBERG KRAVIS ROBERTS & CO. L.P. 11/14/2025 13.26 M $688.77 M   0.00% 6.96%
JANUS HENDERSON GROUP PLC 11/14/2025 8.74 M $453.96 M   -5.77% 4.59%
FARALLON CAPITAL MANAGEMENT LLC 11/14/2025 8.19 M $425.49 M   3.70% 4.30%
AISLING CAPITAL MANAGEMENT LP 11/12/2025 6.09 M $316.29 M   0.35% 3.20%
STATE STREET CORP 11/14/2025 5.61 M $291.19 M   -4.92% 2.94%
INVESCO LTD. 11/13/2025 3.93 M $204.05 M   40.26% 2.06%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 3.91 M $203.11 M   6.20% 2.05%
UBS GROUP AG 11/13/2025 3.86 M $200.67 M   0.00% 2.03%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 11/14/2025 3.85 M $199.73 M   1.18% 2.02%
JANE STREET GROUP, LLC 11/14/2025 3.35 M $173.93 M   -6.23% 1.76%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 2.98 M $154.70 M   1.41% 1.56%
UBS GROUP AG 11/13/2025 2.59 M $134.34 M   -8.04% 1.36%
TWO SIGMA INVESTMENTS, LP 11/14/2025 2.33 M $120.97 M   -0.43% 1.22%
ALLIANCEBERNSTEIN L.P. 11/14/2025 2.33 M $120.95 M   -5.74% 1.22%
D. E. SHAW & CO., INC. 11/14/2025 2.25 M $117.01 M   8.24% 1.18%
GOLDMAN SACHS GROUP INC 11/14/2025 2.21 M $114.74 M   -15.72% 1.16%
CAPITAL RESEARCH GLOBAL INVESTORS 11/13/2025 1.93 M $100.41 M   -51.53% 1.01%
MACQUARIE GROUP LTD 11/13/2025 1.93 M $100.41 M   -7.74% 1.01%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 1.93 M $99.99 M   44.59% 1.01%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 11/14/2025 1.91 M $99.45 M   1.23% 1.01%
SC US (TTGP), LTD. 11/14/2025 1.86 M $96.63 M   0.00% 0.98%
LAURION CAPITAL MANAGEMENT LP 11/17/2025 1.75 M $91.08 M   -27.28% 0.92%
FMR LLC 11/13/2025 1.70 M $88.34 M   -16.11% 0.89%
TWO SIGMA ADVISERS, LP 11/14/2025 1.66 M $86.36 M   -1.26% 0.87%
DRIEHAUS CAPITAL MANAGEMENT LLC 11/14/2025 1.66 M $86.33 M   -1.72% 0.87%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2025 1.57 M $81.42 M   63.08% 0.82%
FRANKLIN RESOURCES INC 11/13/2025 1.44 M $75.00 M   75.80% 0.76%
NORTHERN TRUST CORP 11/14/2025 1.40 M $72.84 M   2.84% 0.74%
CORMORANT ASSET MANAGEMENT, LP 11/14/2025 1.40 M $72.72 M   -12.50% 0.73%
BANK OF AMERICA CORP /DE/ 11/14/2025 1.38 M $71.72 M   25.36% 0.72%
ENSIGN PEAK ADVISORS, INC 11/13/2025 1.35 M $70.20 M   2.71% 0.71%
PRINCIPAL FINANCIAL GROUP INC 11/04/2025 1.27 M $65.83 M   22.99% 0.67%
HOOD RIVER CAPITAL MANAGEMENT LLC 11/14/2025 1.24 M $64.59 M   100.00% 0.65%
DEEP TRACK CAPITAL, LP 11/14/2025 1.20 M $62.33 M   33.33% 0.63%
PICTET ASSET MANAGEMENT HOLDING SA 11/18/2025 1.13 M $58.87 M   -37.30% 0.59%
AMERICAN CENTURY COMPANIES INC 11/12/2025 1.08 M $55.92 M   -1.24% 0.57%
MORGAN STANLEY 11/14/2025 1.05 M $54.79 M   -21.42% 0.55%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 11/14/2025 1.05 M $54.63 M   100.00% 0.55%
WELLINGTON MANAGEMENT GROUP LLP 11/14/2025 1.02 M $52.94 M   1,698.50% 0.54%
BALYASNY ASSET MANAGEMENT L.P. 11/14/2025 1.01 M $52.70 M   -38.19% 0.53%
POLAR CAPITAL HOLDINGS PLC 11/14/2025 981.06 K $50.96 M   100.00% 0.51%
ADAGE CAPITAL PARTNERS GP, L.L.C. 11/14/2025 944.85 K $49.08 M   213.53% 0.50%
CITIGROUP INC 11/10/2025 927.95 K $48.20 M   -25.68% 0.49%
BANK OF NEW YORK MELLON CORP 11/03/2025 927.77 K $48.19 M   69.24% 0.49%
LORD, ABBETT & CO. LLC 11/13/2025 876.88 K $45.55 M   -37.53% 0.46%
SOFINNOVA INVESTMENTS, INC. 11/14/2025 831.85 K $43.21 M   -16.24% 0.44%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 11/14/2025 806.71 K $41.90 M   6.46% 0.42%

BridgeBio Pharma, Inc. institutional Ownership - FAQ's

During the previous two years, 480 institutional investors and hedge funds held shares of BridgeBio Pharma, Inc.. The most heavily invested institutionals were:

VANGUARD GROUP INC: 16.83 M

VIKING GLOBAL INVESTORS LP: 15.98 M

BlackRock, Inc.: 14.41 M

Kohlberg Kravis Roberts & Co. L.P.: 13.26 M

JANUS HENDERSON GROUP PLC: 8.74 M

FARALLON CAPITAL MANAGEMENT LLC: 8.19 M

97.17% of BridgeBio Pharma, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 207.70 M shares in the last 24 months. This purchase volume represents approximately $15.30 B in transactions.